Longitudinal intravital evaluation of tumour vasculature targeted therapies
Tumour growth and metastasis are dependent on the formation and maintenance of a dedicated microvascular network. Angiostatin4.5 (AS4.5) is a naturally occurring anti-angiogenic agent known to inhibit angiogenesis in vitro and tumour growth in vivo.
Main Author: | Guerreiro-Lucas, Luciano Andre |
---|---|
Published: |
University of Nottingham
2008
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.495592 |
Similar Items
-
Bacteriolytic therapy of tumours
by: Dwivedi, Anupma
Published: (2012) -
Mechanisms of fluoro-2-deoxyglucose retention by tumour cells responding to therapy
by: Sharma, Rituka I.
Published: (2008) -
The development of novel thymidylate synthase inhibitors targeted to a-folate receptor overexpressing tumours
by: Theti, Davinder Singh
Published: (2002) -
The role of nitric oxide synthase expressed by cytokine-induced macrophages on HIF-1 regulation in tumour cells and their response to therapy
by: Mehibel, Manal
Published: (2009) -
Magnetic resonance guided tumour ablation
by: Dick, Elizabeth Ann
Published: (2003)